Format

Send to

Choose Destination
Rev Med Inst Mex Seguro Soc. 2019 Jul 31;57(2):74-81.

Esophageal candidiasis in patients from a specialty hospital

[Article in Spanish; Abstract available in Spanish from the publisher]

Author information

1
Instituto Mexicano del Seguro Social, Hospital de Especialidades “Dr. Bernardo Sepúlveda”, Laboratorio de Investigación Médica en Dermatología y Micología. Ciudad de México, México

Abstract

in English, Spanish

Background:

Esophageal candidiasis (EC) is the most common cause of infectious esophagitis. So far, its main risk factor has been HIV infection; in recent years, EC has been favoured by the increasing of diabetes mellitus, wide-spread use of acid-lowering agents, broad-spectrum antibiotics, and inhaled steroids. In Mexico EC has been poorly studied.

Objectives:

To determine the clinical and epidemiological characteristics of EC, and to identify its etiological agents as well as its antifungal susceptibility.

Methods:

Patients who revealed the presence of scattered white spots through an upper gastrointestinal system endoscopy, in a period of one year, in a tertiary care hospital, were included. Samples from patches were collected for microscopic examination, culture, and susceptibility tests.

Results:

Out of 1763 patients studied, 23 had scattered white spots, and most of them presented Kodsi grade I; 13 were men; half of the patients were between the ages 20 to 40; main comorbidity was liver cirrhosis; use of omeprazole was significant. 22 isolates were obtained from 17 patients. The most frequent species were C. albicans (14) and C. parapsilosis (3). In five cases we found a two-species association v. g. Candida famata with Trichosporon mucoides. Half of the isolates showed resistance to one or several antifungal drugs.

Conclusions:

EC frequency in this study was similar to other studies’ results. Obtained isolates showed high resistance to azolic compounds and to caspofungin, which is relevant information to take a therapeutic decision.

KEYWORDS:

Candidiasis; Esophagus; Candida albicans; Antifungal Agents

PMID:
31618561

Supplemental Content

Loading ...
Support Center